Pan-Cancer Analysis of the Roles and Driving Forces of RAB42

Mingzhu Zheng1, Wenhao Wang1, Yulan Bu2

  • 1Department of Oncology, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang 261031, China.

Biomolecules
|January 21, 2023
PubMed

Insights

RAB42, a RAS family member, is upregulated in most cancers, correlating with poor prognosis and increased immune cell infiltration. This study identifies RAB42 as a potential diagnostic, prognostic, and immunotherapy biomarker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • The roles and regulatory mechanisms of RAB42, a RAS family member, in tumor development are largely unknown.
  • Understanding RAB42's function is crucial for identifying new cancer biomarkers and therapeutic targets.

Purpose of the Study:

  • To conduct a comprehensive pan-cancer analysis of RAB42's roles and regulatory mechanisms.
  • To investigate RAB42's potential as a diagnostic, prognostic, and predictive biomarker for cancer immunotherapy.

Main Methods:

  • Utilized bioinformatics tools (Sanger Box, ACLBI, TIDE) for pan-cancer analysis of RAB42 expression, prognosis, and immune features.
  • Performed enrichment analysis to identify associated biological functions and pathways.
  • Conducted drug sensitivity analysis and virtual screening to identify potential therapeutic agents targeting RAB42.

Main Results:

  • RAB42 expression is upregulated in the majority of tumors and associated with poor prognosis.
  • RAB42 expression positively correlates with immune cell infiltration and immune checkpoint gene expression, indicating a role in the tumor immune microenvironment.
  • RAB42 demonstrates high predictive value for immunotherapy efficacy and is linked to epigenetic factors like DNA methylation and non-coding RNAs.

Conclusions:

  • RAB42 serves as a valuable diagnostic and prognostic biomarker across various tumor types.
  • RAB42 represents a promising therapeutic target for cancer immunotherapy, with potential drug sensitivities identified.

Related Concept Videos

Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.0K
Rab Cascades01:25

Rab Cascades

Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
2.7K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K